Fort Worth Based Alcon Announces FDA Approval of Simbrinza Suspension, A New Beta Blocker-free, Fixed-Combination Therapy For Glaucoma

Read about how Fort Worth Based Alcon Announces FDA Approval of Simbrinza Suspension, A New Beta Blocker-free, Fixed-Combination Therapy For Glaucoma.

http://bionews-tx.com/news/2013/04/22/fort-worth-based-alcon-announces-fda-approval-of-simbrinza-suspension-a-new-beta-blocker-free-fixed-combination-therapy-for-glaucoma/